Nektar Therapeutics

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$67.10

-1.26 (-1.84%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 83%

Hold 3 17%

Sell 0 0%

Price Target

Analyst Price Target -37.1% upside

Low Target $31.85

Average Target $42.23

High Target $63.47

Current Price $67.10

Current
$67.10

Target
$42.23

$31.85 $42.23 avg $63.47

Scenario Analysis

Bear Case

$31.85

-52.5%

Low target

Base Case

$42.23

-37.1%

Avg target

Bull Case

$63.47

+-5.4%

High target

Risk/Reward

0.1x

Unfavorable

Price in Context

52-Week High

$109.00

-38.4% from high

52-Week Low

$33.40

+100.9% from low

Target vs 52W High

$42.23

-61.3% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+14.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.2%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+6.5%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+22.2%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+178.7%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-38.0%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+194.2%